Single-dose of Nalmefene to Modulate Neural Alcohol Cue Reactivity
Clinical trial NCT02372318 · TERMINATED
Trial details
- NCT number
- NCT02372318
- Sponsor
- Central Institute of Mental Health, Mannheim
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-05-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.